Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance

Molecular portraits of human breast tumours

Charles M. Perou, Thérese Sørlie, Michael B. Eisen et al. · Nature · 2000 · 16.3K citations

Medicine, Molecular Biology, Oncology +14

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Anthony Howell, Jack Cuzick, M Baum et al. · The Lancet · 2005 · 2.3K citations

Medicine, Oncology, Breast Oncology +6

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

Akihiko Taguchi, David C. Blood, G. Del Toro et al. · Nature · 2000 · 1.2K citations

Medicine, Cancer Biology, Oncology +14

Neoadjuvant Treatment of Postmenopausal Breast Cancer With Anastrozole, Tamoxifen, or Both in Combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined With Tamoxifen (IMPACT) Multicenter Double-Blind Randomized Trial

Ian E. Smith, Mitch Dowsett, S. Ebbs et al. · Journal of Clinical Oncology · 2005 · 772 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Identification of molecular apocrine breast tumours by microarray analysis

Pierre Farmer, Hervé Bonnefoi, Véronique Becette et al. · Oncogene · 2005 · 767 citations · Full text

Medicine, Molecular Biology, Oncology +14